TITLE

Alere Upsizes Term Loan Again, to $925M

AUTHOR(S)
Colter, Allison Bisbey
PUB. DATE
July 2011
SOURCE
High Yield Report;7/4/2011, p9
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the move by Waltham, Massachusetts-based Alere to expand its term B loan again to 925 million U.S. dollars from 875 million U.S. dollars.
ACCESSION #
66187457

 

Related Articles

  • Alere Increases Size, Boots Spread on TL. Colter, Allison Bisbey // High Yield Report;7/4/2011, p2 

    The article reports on the move by medical diagnostic manufacturer Alere to expand its term loan (TL) B to 875 million U.S. dollars from 750 million U.S. dollars.

  • Alere acquires additional 5M shares of Axis-Shield.  // Medical Device Daily;10/3/2011, Vol. 15 Issue 188, p3 

    The article reports that an additional shares of Axis-Sheild stock were purchased by Alere which brings its total current ownership position to 21.98% of Axis-Sheild's issued and outstanding ordinary share capital.

  • Alere Taps HY Market for $450M. Sheahan, Matthew // High Yield Report;12/3/2012, p27 

    The article reports on the sale of a 450 million U.S. dollar bond in 7.25 percent senior notes by Alere of Waltham, Massachusetts due 2018.

  • Financings roundup.  // Medical Device Daily;11/29/2012, Vol. 16 Issue 231, p3 

    The article announces the intention of Alere to offer 450 million U.S. dollars of senior notes due 2018 through a private placement, subject to market and other conditions.

  • Alere Adds $450M to Bond Queue. Sheahan, Matthew // High Yield Report;12/3/2012, p16 

    The article reports that Alere, a Waltham, Massachusetts-based health care management company, is selling 450 million U.S. dollars in senior notes due 2018.

  • Agreements/contracts.  // Medical Device Daily;8/12/2011, Vol. 15 Issue 151, p3 

    The article reports on license agreement signed between VitaPath Genetics and Alere for VitaPath's spina bifida risk assessment assay.

  • Deals roundup.  // Medical Device Daily;12/2/2011, Vol. 15 Issue 230, p3 

    The article reports on the equity interest in Arriva Medical sold by Palm Beach Capital Fund III to Alere.

  • Financings roundup.  // Medical Device Daily;6/1/2011, Vol. 15 Issue 105, p2 

    The article reports on the launching of certain consent solicitations relating to the 9.0% senior subordinated notes of Alere due 2016, as well as the 8.625% senior subordinated notes due 2018 and 7.875% senior notes due 2016 of the company.

  • A Closer Look: STD/HIV Testing Devices.  // Clinical Lab Products;Jun2014, Vol. 44 Issue 6, p9 

    The article previews several sexually transmitted disease (STD) and HIV testing devices including the Alere Determine HIV-1/2 Ag/Ab Combo from Alere Inc., Bio-Rad's Droplet Digital polymerase chain reaction (ddPCR) system and the MultiCode-RTx HSV 1 and 2 kit tests for herpes simplex virus 1 and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics